Terug
Dagbereik
€ 14,00
€ 14,00
52-Weeksbereik
€ 0,78
€ 25,00
Volume
5.403.471
50D / 200D Gem.
€ 12,84
/
€ 6,40
Vorige Slotkoers
€ 14,00
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,4 | 0,3 |
| P/B | 4,0 | 2,9 |
| ROE % | -54,3 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 14,00
+0.0%
Forward WPA
-€ 1,77
Omzet Sch.
13 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,09
€ 0,09 – € 0,09
|
390 M | 1 |
| FY2028 |
-€ 0,55
-€ 1,32 – € 0,97
|
270 M | 5 |
| FY2027 |
-€ 1,60
-€ 2,27 – -€ 1,14
|
31 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,04 — conservative balance sheet
Negative free cash flow of -131,11M
PEG of 0,03 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-54,27%
ROIC-42,04%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,04
Current Ratio17,97
Interest Coverage0,00
Waardering
P/E Ratio
-7,43
P/B Ratio3,95
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -135,12M |
| ROE | -54,27% | ROA | -48,86% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131,11M |
| ROIC | -42,04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 17,97 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,43 | P/B Ratio | 3,95 |
| P/S Ratio | N/A | PEG Ratio | 0,03 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,00B | Enterprise Value | 988,04M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -135,12M | -192,96M | -108,43M | -83,75M | -28,17M |
| EPS (Diluted) | -1,97 | -3,30 | -2,06 | -1,69 | -0,56 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -148,45M | -207,99M | -113,14M | -67,15M | -7,05M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 276,56M | 277,69M | 371,40M | 291,48M | 245.000,0 |
| Total Liabilities | 22,52M | 33,77M | 17,51M | 12,28M | 30,90M |
| Shareholders' Equity | 254,05M | 243,92M | 353,90M | 279,20M | -30,65M |
| Total Debt | 10,79M | 12,51M | 1,56M | 0,0 | 12,65M |
| Cash & Equivalents | 27,26M | 51,58M | 64,82M | 70,79M | 244.000,0 |
| Current Assets | 229,63M | 264,35M | 330,69M | 263,02M | 245.000,0 |
| Current Liabilities | 12,78M | 22,27M | 16,36M | 12,28M | 1,40M |